Impact of P53 and SIRT1 in Type 2 Diabetes
Recruiting · NCT03925714 · Interventional (participants receive a specific treatment) · Lead sponsor: Sherief Abd-Elsalam
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Prediabetic subjects.
Exclusion criteria
- Confirmed diabetes.
- Hepatic or renal impairment.
Where it is running
1 location listed.
- Sherief Abd-Elsalam - Cairo, Egypt